ISRCTN17834262已完成3 期
A randomized, double-blind, multicenter study to evaluate the efficacy and safety of ethyl lauroyl arginine hydrochloride (ELAH) formulation administered as a nasal spray to reduce viral load in the nasal area in subjects with coronavirus disease 2019 (COVID-19)
Salvacion LLC0 个研究点目标入组 30 人开始时间: 2022年4月26日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
2022 Preprint results in https://doi.org/10.21203/rs.3.rs-1432140/v1 (added 09/08/2022)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Signed informed consent
- •2. Confirmed for Covid-19 infection by RT-PCR tests
排除标准
- •1. Allergy to ELAH
- •2. Females who were breast feeding or lactating
- •3. History of severe respiratory infections
- •4. Have received period Covid treatment
- •5. Participated in any interventional drug trial in previous 30 days
研究者
相似试验
已完成
2 期
Study to verify the effectiveness and safety of the modified isothymol or carvacrol compound against SARS-CoV-2 in COVID-19 patientsCOVID-19 (SARS-CoV-2 infection)Infections and InfestationsISRCTN15363958Instituto Venezolano de Investigaciones Científicas600
已完成
2 期
Cediranib maleate with or without gefitinib in treating patients with recurrent or progressive glioblastomaCancerISRCTN00549973niversity College London (UK)38
已完成
4 期
Evaluation of Lactosectan versus placebo to compare the effectiveness and safety in treating adult patients with intolerance to certain foods, primarily lactose intoleranceactose intoleranceNutritional, Metabolic, EndocrineLactose intoleranceISRCTN18410689ovintethical Pharma SA60
已完成
2 期
stekinumab in adolescents with recent-onset type 1 diabetesNutritional, Metabolic, EndocrineType 1 diabetes mellitusISRCTN14274380Cardiff University88
已完成
不适用
Rifaximin to reduce infection in decompensated cirrhosisDigestive SystemDecompensated cirrhosisISRCTN10994757Imperial College London78